. In addition, the recent development of PET/MRI scanners has led to further advances in cardiovascular imaging (17) .
Herein, we review the imaging features of cardiac tumors and present images of cardiac diseases that were obtained using various techniques at our institution.
Computed tomography (CT)
CT can provide excellent anatomical and morphological information and clearly demonstrate calcification and fat components (15, 18) . Tumor vascularity can also be assessed using iodine contrast media. Multi-detector-row CT scans provide a wide field of view and a high spatial resolution, can be performed with and without electrocardiography (ECG)-gated protocols, and do not take long. Three-dimensional or multiplanar reconstruction images can also be obtained.
Tumor movement and the locations of cardiac valves and the myocardium can be evaluated on ECG-gated cine-CT. In addition, advances are being made in low radiation dose and high spatial resolution techniques (19) .
Magnetic resonance imaging (MRI)
MRI is superior to tissue characterization using numerous scan parameters. (14, 15, (20) (21) (22) .
Fluorodeoxyglucose-positron emission tomography/CT (FDG-PET/CT)
FDG is a glucose analog that has been labeled with the fluorine-18 positron and accumulates in some tumors and active inflammatory lesions, such as cardiac sarcoidosis and vasculitis (23, 24) . FDG-PET/CT can provide both morphological and metabolic images of the whole body in a single session, and is very useful for tumor staging, detecting recurrence, predicting prognosis, and therapeutic monitoring (25) (26) (27) 
FDG-PET/MRI
PET/MRI scanners are a newly developed type of clinical imaging system (34) . They benefit from the advantages of both PET, which exhibits superior performance during metabolic imaging, and MRI, which demonstrates superior performance during morphological and tissue characterization (17, 34) . Regarding the differences between PET/CT and PET/MRI, PET/MRI reduces the patient's radiation exposure, 
Image presentation

Benign tumors
Myxoma
Myxoma accounts for 25-50% of primary cardiac tumors and is the most common primary cardiac tumor affecting adults. It predominantly arises in females in their 30s to 40s.
Myxomas occur in the left and right atria in 60-75% and approximately 20% of cases, respectively (18, 37) . Most myxomas adhere to the atrial septum, and their mobility can be assessed using echocardiography or cine-MRI. Myxomas can be spherical or ovoid shaped; have smooth margins; consist of various components, such as myxoid and fibrous tissue and calcifications; and can exhibit hemorrhaging. Myxomas display low to iso-density on non-contrast-enhanced CT (14, 18) . Calcification is more common in right atrial masses and is clearly shown on CT. On MRI, myxomas typically display low intensity on T1WI and high intensity on T2WI; however, they sometimes exhibit heterogeneous signal intensity due to mucoid degeneration or hemorrhaging (21) . Faint contrast enhancement is seen in the arterial phase, and mild contrast enhancement is observed in the delayed phase (Fig. 1a-c) . On FDG-PET/CT, myxomas display faint to mild FDG uptake. It is important to differentiate myxomas from intracardiac thrombi. Thrombi exhibit high intensity on MRI T1WI, but do not display contrast enhancement on CT or MRI or FDG avidity on FDG-PET/CT (13) (Fig. 1e, f) . CT is superior to MRI for detecting calcification (18) The myxoma was located in the left atrium and was attached to the atrial septum. The base of the tumor appeared to be located in the atrial septum. On MRI, the myxoma exhibited low intensity on T1WI, high intensity on T2WI, and heterogeneous contrast enhancement. Echocardiography showed a heterogeneous echoic mass. e, f: CT and FDG-PET/CT image of a thrombus in the left atrium The thrombus displayed low density on CT, and no FDG uptake was seen within the thrombus.
fibromas exhibit iso-or low intensity on T1WI and low intensity on T2WI, reflecting the fibrous tissue they contain.
The contrast enhancement patterns of cardiac fibromas vary.
LGE is seen in the delayed phase due to the presence of fibroblasts interspersed among a large amount of collagen, and this has been suggested to be another characteristic finding of cardiac fibromas (38) . Masuda et al. reported that the abovementioned signal intensity pattern and the presence of
LGE on MRI are very useful for differentiating an intensely FDG-avid cardiac fibroma from other malignant tumors (39) .
Malignant tumors
Malignant lymphoma Lymphomas commonly demonstrate strong FDG uptake. In the present study, the mean SUVmax of DLBCL was 25.9, which was significantly higher than those of other cardiac tumors (the mean SUVmax of malignant cardiac tumors was 10.
5, and that of benign cardiac tumors was 3.4) ( 
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